Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
765
-
Total 13F shares, excl. options
-
257M
-
Shares change
-
-5.29M
-
Total reported value, excl. options
-
$17.1B
-
Value change
-
-$821M
-
Put/Call ratio
-
1.77
-
Number of buys
-
302
-
Number of sells
-
-518
-
Price
-
$66.83
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q3 2024
1,064 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q3 2024.
Moderna, Inc. - COMMON STOCK (MRNA) has 765 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 257M shares
of 385M outstanding shares and own 66.76% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (42.5M shares), VANGUARD GROUP INC (40.2M shares), BlackRock, Inc. (25M shares), FMR LLC (17.4M shares), STATE STREET CORP (16.8M shares), Theleme Partners LLP (7.23M shares), GEODE CAPITAL MANAGEMENT, LLC (7.07M shares), WELLINGTON MANAGEMENT GROUP LLP (5.22M shares), Flagship Pioneering Inc. (4.63M shares), and Invesco Ltd. (4.03M shares).
This table shows the top 765 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.